1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

09 Apr 2024
Admin
News Article

New Partnership Formed for Improving China’s Health

New research partnership with UK to improve health in China’s Greater Bay area

Overview

Researchers at the University of Birmingham, UK and Seventh Affiliated Hospital of Sun Yat-sen University, China have joined forces to launch a joint clinical research institute that aims to improve healthcare outcomes in China’s Greater Bay Area and beyond.

First-of-a-Kind

The University of Birmingham-Sun Yat-sen Seventh Hospital Joint Clinical Research Institute is the first such international partnership in Shenzhen and will focus on the high-quality development of clinical research.

Aim for Partnership

For exploring clinical research innovation and developing translational medical technology, the partnership aims to create international multi-centre clinical research partnerships and develop the best new clinical research talent.

Agreement Signed

Professor Jon Frampton, Deputy Pro-Vice Chancellor (China) at the University of Birmingham and He Yulong, President of Zhongshan Seventh Hospital, signed a cooperation agreement on the establishment of a joint clinical research institute at a grand unveiling ceremony held at Sun Yat-sen Seventh Hospital.
Professor Frampton commented, “Our partnership through this new Institute will promote the cultivation of high-level research talent and the application of high-quality clinical research projects.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!